Apr 24, 2019 / 09:00AM GMT
Toshiaki Itagaki - Chugai Pharmaceutical Co., Ltd. - EVP, CFO and GM - Finance Supervisory Division, Finance & Accounting Dept. & IT Supervisory Division
Good evening, ladies and gentlemen. I am Toshiaki Itagaki from Chugai Pharmaceutical. Thank you very much for joining us from late afternoon. With regard to the presentation material, I have made some changes to the way results are described and moved some of the slides, which used to be in the main text to the appendix, as well as added some new ones. So I will point to them as I go along. I hope you will stay with us till the end.
Please take a look at Page 2. This is a 1-page summary of the results intended to make the result easier to see.
In this first quarter, we saw increased revenues and operating profit with profit posting a double-digit growth. We achieved record high Q1 results in terms of revenues, operating profits and net income.
Furthermore, strong progress has been made against the full year forecast announced at the beginning of the fiscal year. With 33.5% of the full year forecast already posted in
Q1 2019 Chugai Pharmaceutical Co Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot